AN ANTIVIRAL SUBSTANCE FROM PENICILLIUM FUNICULOSUM : I. EFFECT UPON INJECTION IN MICE WITH SWINE INFLUENZA VIRUS AND COLUMBIA SK ENCEPHALOMYELITIS VIRUS by Shope, Richard E.
AN ANTMRAL  SUBSTANCE FROM PENICIIff.IUM FUNICULOSUM* 
I. EF?ECr zrPON  INFECTION IN MICE WITH SWINE INFLUENZA VIRUS AND 
COLUMBIA SK ENCEPHALOMYELITIS VIRUS 
BY RICHARD E. SHOPE, M.D. 
(From the Department  o/Animal  and Plant Pathology o/The Rockefeller Institute/or 
Medical Research, Princeton, New Jersey, and the Merck Institute for 
Therapeutic Research, Rahway, New Jersey) 
(Received for publication, December 11, 1952) 
A  penicillium isolated from  the isinglass cover of a  photograph  of my wife' 
Helen, on Guam, near the end of the war in 1945,  appeared in preliminary ex- 
periments  to  be  capable  of  elaborating  a  substance  active  therapeutically 
against  swine  influenza  virus.  Because  it possessed  this  property  the  culture 
was submitted to Dr.  Charles Thorn and Dr. Kenneth Raper for identification. 
They  classified it  as Penicillium funiculosum  (Thorn)  and  have  described its 
appearance  and  cultural  characteristics  in  the  recent  edition  of  their  book, 
Manual  of  the  Penicillin  (1).  They  have  assigned  it  the  culture  designation 
NRRL2075.  A  very  preliminary  report  of  the  therapeutic  results  obtained 
with broths in which P. funicuIosum  was  grown when  used against infections 
in mice with swine influenza virus has been published in abstract (2). It is the 
purpose of the present paper to outline the findings in somewhat greater detail 
and to report the therapeutic effect of a substance elaborated by P. funiculosum 
against infections in mice with Columbia SK encephalomyelitis virus. 
Materials  and Methods 
Viruses--Swine  Influenza.--Strain  15  swine  influenza  virus, administered intranasally 
under light anesthesia with ether was used throughout to induce  experimental infections. 
10 to 100 times the amount of virus required to kill all control mice was used for infection 
and for most experiments this was a 10  ~  or 10  --n dilution of infected mouse lung. 
Columbia SK Encepkalomyelitis.--The strain of SK virus used had been obtained from 
Dr.  Claus W. Jungeblut of Columbia University, and was regularly and highly lethal for 
mice  when  administered intracerebrally, intraperitoneally, or  subcutaneously.  Infections 
to be treated with the antiviral substance were induced by either intraperitoueal or sub- 
cutaneous inoculation with from 10 to 1000 times the amount of virus that regularly killed 
all untreated control animals. In most of the experiments this amounted to 0.5 cc. of a 1 X 
10  --s to 1 X  10  -7 dilution of infected mouse brain. Pools of brains from  10 to 15 infected 
mice, harvested when part of the animals were dead and the remainder were showing char- 
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acteristic signs of infection, were prepared in 5 per cent suspension in buffered saline (pH 7.3) 
and divided among a number of screw-capped vials for storage frozen under CO~. until ready 
for use. Kept in this way, the virus retained an adequate potency for experiment and a single 
batch sufficed for 3 to 4 months of work. Dilution of the virus suspension to the concentra- 
tion desired in an individual experiment was made just prior to use and the diluted virus 
was kept in an ice bath during the time of its administration. 
Mice.--In the portion of this work carried on at the Rockefeller Institute, the Rockefeller 
Institute Swiss strain of mice was used while the Carworth Farms CFW strain of mice was 
employed in the work at  the Merck Institute. Animals weighing from 12  to  16 gm. were 
used. 
Cultivation of Penicillium  funiculosum.--P, funiculosum  was  maintained  for  study by 
serial transfer at 2 to 3 week intervals on Sabouraud's agar slants or was stored in a sporu- 
lated form on sterilized dirt, sawdust, or wheat grains in cotton-plugged test tubes at refrig- 
erator temperature. 
TABLE  1 
Composition of Medium  in  Which  Penicillium  funiculosum  Produces Antiviral  Substance 
KH2PO, 
KC1 
MgSO, 
NaNO3 
ZnSO, 
FeSO, 
Rochelle salts 
Glucose 
Yeast extract 
gm. 
1 
0.5 
0.5 
3.0 
0.001 
0.01 
0.01 
40.0 
10.0 
The above salts, glucose,  and yeast extract are dissolved in 1000 cc. distilled H~O. 
The fluid medium in which P. funiculosum  elaborates a substance possessing therapeutic 
activity for swine influenza and SK virus infections has undergone numerous modifications 
during the course of the work, but the formula which appears most regularly to be satis- 
factory has the composition shown in Table I. The medium is distributed in either 45  cc. 
amounts in 125 cc. Erlenmeyer flasks or 120 cc. amounts in 32 oz. Blake bottles and auto- 
claved. It has a pH of between 5.5 and 6.5 and requires no adjustment. 
Preparation of the A ntiviral Substance.--In preparing the antiviral substance, flasks of the 
medium were inoculated either with a piece of the surface growth of P. funiculosum  from a 
Sabouraud's agar slant, or a suspension of the spores from such a slant in distilled water or 
physiological salt solution. Stationary cultures were incubated for from 6 to 12 days (usually 
7 or 8)  on a  table or shelf in a  room whose temperature could be maintained at ±26°C., 
and  were usually not disturbed between the  time of inoculation and harvest. The shake 
cultures were incubated for from 48 to 72 hours in the same room on a  mechanical shaking 
machine. Stationary cultures fur~shed a good yield of antiviral substance much more regu- 
larly than those incubated on a shaking machine. After they had grown for 7 or 8 d~ys they 
had ordinarily a  heavy surface pellicle  ranging in color from  greenish yellow  to red, and 
considerable mycelium was present in the fluid portion of the culture beneath the pelllcle. 
The broth of such cultures frequently had an orange or red tinge. In cultures incubated while 
shaken, there was, of course, no surface pellicle and instead they usually consisted, after 48 
hours, of a viscous mass of pale yellow to gray mycelium in balls or loose clumps. 
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gauze, using suction or pressure to facilitate filtration, in order to remove floating mycelium. 
If sterile preparations were desired, the broths were filtered further through Seitz pads. 
EXPERIMENTS  VCITH SWINE INFLUENZA VIRUS INFECTIONS OF MICE 
Tests of mold  preparations  for therapeutic  activity in mice  infected with 
swine influenza virus were conducted  in the following manner:-- 
White mice in groups of from 6 to 12 animals per cage were infected with swine influenza 
virus as described  above. Animals that were to serve as controls received 0.3 or 0.5 cc. of 
uninoculated culture broth intraperitoneally either 2 or 3 times in the first 24 hours after 
infection.  If 3 injections were given, the time intervals after infection were usually 1, 3, and 
24 hours, while if only 2 treatments were administered the injection at I hour after infection 
was omitted. In occasional experiments 1 injection of broth was given several hours prior to 
infection with virus.  Mice in which  various mold preparations were to be tested received 
them in the same amounts, by the same route, and on the same injection schedule as the 
controls. 
Mice dying during the first 48 hours after infection were eliminated from consideration in 
the experimental results. Such toxic deaths from f~nicu~osum culture fluids were quite rare. 
Mice dying later were autopsied to determine whether death had resulted from influenza 
virus infection.  12 days was selected as the period of observation, since it had been our ex- 
perience  that mice which lived this long were very likely to survlve indefinitely.  All mice 
still alive on the 12th day were killed, autopsied, and examined  for influenzal lesions. For 
purposes of scoring the result they were recorded as having succumbed on the 12th day. 
The experimental results were  scored by totalling the days of death of all mice in the 
group and dividing this total by the number of mice in the group to obtain the survival 
average in days for each group. A perfect score under this method of tabulation was, there- 
fore, 12. 
Results of Swine Influenza  Virus Experiments 
Two  typical  experiments  in  which  both  favorable  and  unfavorable  thera- 
peutic results seemed to have been obtained with broth cultures prepared from 
colony isolates are given in Tables II and III. 
In the experiments recorded in Table II the broths harvested from 8  of the 
colony isolates from a  single seeding of P. funiculosum  (A-80 to A-88) failed to 
exert any  therapeutic  effect  against  swine  influenza virus  infections  in  white 
mice, and all 10 mice in each group succumbed typically. The broths from the 
remaining subcultures of the same seeding of P. funiculosum,  on the other hand, 
appeared to exert a  favorable therapeutic effect and  saved all or a  portion of 
the  treated mice.  On  the  12th  day after infection,  when  this experiment was 
terminated, part of the groups of surviving mice were autopsied and examined 
for lesions, and part were tested for immunity to swine influenza by infection 
with a  large dose of virus intmnasally. Roughly 75  per cent of the mice autop- 
sied on the 12th day showed residual influenzal lesions in their lungs and about 
the same per cent of those  tested for  immunity survived the  challenge infec- 
tion. It was apparent from  these results that treatment had been adequate to 
avert infection completely in about  one-fourth  of the surviving animals while 
in the remaining three-fourths, though it had saved their lives, it had not pre- 604  AN ANTIVIRAL SUBSTANCE FROM  P. FUNICULOSU~. I 
vented the development of immunity or  sufficient infection to  cause minimal 
lung lesions. 
TABLE II 
Treatment of Swine Influenza Virus Infections  in Mice with a Substance Produced by Penit,  il- 
lium funiculosum* 
Broth culture  of colony  isolator  Survival  average  No. surviving~ 
A-63 
A-65 
A-66 
A-67 
A-68 
A-69 
A-70 
A-71 
A-72 
A-73 
A-74 
A-76 
A-77 
A-78 
A-79 
A-80 
A-81 
A-82 
A-83 
A-84 
A-85 
A-87 
A-88 
A-89 
A-90 
A-91 
A-92 
Broth 
tc 
days 
10.2 
12.0 
11.7 
12.0 
12.0 
12.0 
11.3 
12.0 
12.0 
11.3 
11.6 
11.5 
12.0 
12.0 
12.0 
6 
10 
9 
10 
(control) 
tc 
4.2 
4.4 
4.4 
4.1 
4.4 
4.4 
6.5 
7.1 
9.6 
11.7 
9.4 
9.9 
7.5 
5.0 
10 
10 
8 
10 
10 
7 
9 
8 
10 
10 
10 
* Treatment schedule, 0.3 cc. intraperitoneally  to each mouse 2 hours before and 3 and 
24 hours after infection with swine  influenza vires. 
:~ Cultures of individual colonies isolated from a single plate seeding of P. funic~dosum. 
§ 10 mice in each treatment group. 
The experiments outlined in Table III, conducted about  1 year later than 
those  given  in  Table  II,  record  less  striking  therapeutic  effects.  The  crude 
broths of  3  of  the  cultures  (I-59-61)  exerted  little or  no beneficial influence. 
However, when these broths were concentrated 2  times by evaporation to half 
their  original volume,  their  therapeutic  effectiveness appeared  improved.  In 
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in  therapeutic  efficacy on  similar  concentration.  These  findings  indicate  that 
the antiviral  substance  elaborated  by P. funiculosum  is capable of concentra- 
tion by appropriate procedures. 
Comment on Swine Influenza  Virus Experiments 
The  findings  that  have  been  outlined  represent  some  of  the  best  but  also 
some  of the  worst  therapeutic  results  obtained  in  the  treatment  of swine  in- 
fluenza virus infections in mice during the course of the first 2 years of our work 
TABLE  III 
Treatment of Swine Influenza  Virus Infections in Mice witk a Substance Produced by Penicil- 
lium funiculosum * 
Broth culture of colony isolate~  Survival aversge  No. surviving§ 
1-59 
1-59 (concentrated  2 X) 
1-60 
1-60  "  " 
1-61 
1-61  "  " 
1-73 
1-76 
1-79 
1-81 
1-83 
Pool of above 5 preparations concentrated 2 X 
Broth (control) 
c~  c~ 
days 
6.0 
8.3 
5.6 
6.4 
6.1 
7.7 
8.5 
7.4 
6.6 
8.3 
7.9 
9.9 
5.9 
5.9 
* Treatment schedule, 0.3 cc. intraperitoneally  to each mouse, 1, 3, and  24 hours  after 
infection. 
Cultures  of individual  colonies isolated from a single plate  seeding of P. funi~uJosum. 
§ 7 mice in each treatment group. 
with  P. fun~culosum.  Over  2,000  culture  isolates  of the  mold were  tested  for 
activity against swine influenza virus during that time, and of these about half 
gave  either  completely negative  or very unimpressive  results.  The  remaining 
half  gave  results  which  ranged  from  the  prolongation  of  life  of  the  treated 
animals  to the actual  saving of a  part or the majority of them.  No reason for 
the inconstancy of the results  is apparent  and  no explanation  for the periodic 
variations  and  fluctuations  in  therapeutic  potency  of  the  different  prepara- 
tions can now be given. 
Consideration  of the findings over the period  of 6 years during which work 
has been in progress indicates that cultures grown during the first  2 years were 
uniformly  considerably  more  active  in  favorably  influencing  the  outcome  of 
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ing the last 4 years. The suggestion is obvious that our culture of P. funiculosum 
has  lost  some  therapeutic  property  which  it  originally possessed  and  which 
accounted for its favorable effect on mice inoculated with swine influenza virus. 
The mold has been subjected to numerous procedures and manipulations in 
an attempt to return it to its original state, but nothing tried has enabled the 
culture  to  regain  its  therapeutic  effect for  swine  influenza virus  infections of 
mice. 
EXPERIMENTS WITH COLUMBIA SK ]ENCEPHALOMYELITIS VIRUS INFECTIONS 
OF MICE 
Partly because our  culture  of P. funiculosum  appeared to have  largely lost 
its capacity to elaborate the antiviral substance active against swine influenza 
virus, and partly to learn whether it still possessed activity against a virus other 
than  this,  experiments  with  the  Columbia  SK  encephalomyelitis virus  were 
initiated during the 4th year of our study. By this time our culture of P. funi- 
culosum no longer produced the substance that during the first 2 years had been 
found to be active against swine influenza virus infections. The work with the 
SK virus was thus begun with a  culture of P. funiculosum that, to judge from 
our  findings,  had  changed  from  one  which  in  1946  and  1947  had  been  quite 
active in elaborating a  substance that was therapeutically active against murine 
swine  influenza to one  which  in  1949  had lost this activity. 
During the course of our work we had modified our methods of growing P. 
funiculosum  in  the  attempted  production  of  the  antiviral  substance,  though 
these  changes did not  appear to be responsible for the loss of activity of the 
culture  because  reversion  to  the  initial  culture  methods  failed also  to  yield 
preparations that were  active  against swine  influenza virus infections. At the 
time  that  work  with  SK virus  was  begun,  and  throughout  the  remainder  of 
our  work,  the  following method  of  growing  the  mold for  production  of anti- 
viral substance was adopted. 
Preparation of Antiviral Substance Active against SK Virus.--In  the present and subse- 
quent experiments only stationary cultures of P. funiculosum grown in 32 oz. Blake bottles 
containing 120 co. of the medium described  earlier were employed.  The bottles were laid 
on their flat sides, slightly tilted to prevent wetting of the cotton plugs by the medium. 
This gave a large area for surface growth. Incubation was at -¢-26°C. for 10 days. Spores of 
P. funiculosum stored on dry grains of sterile wheat were used as inocuhim,  transferring 1 
or 2 grains of spore-dusted wheat to each bottle of medium or shaking such wheat with broth 
in an approximate proportion of 1 grain of wheat to each 2 cc. of broth and using  1 cc. of 
the resulting spore suspension as inoculum for the Blake bottle cultures. 
In harvesting, after 10 days' incubation, the fluid portions of the culture were filtered 
through sterile gauze-faced milk filter pads in a Buchner  funnel  with suction.  In early ex- 
periments reported in this paper the fluid thus obtained was used to treat the infected mice. 
Later, when it was subsequently found that the pericles possessed much more antiviral ac- 
tivity than did the fluid portions of the cultures the process of harvesting was further modi- 
fied. The fluid portions of the 10 day old cultures were filtered through gauze as before, while 
the moist fleshy pericles remained on the gauze pad in the funnel. Mter being sucked free 
of adherent fluid, the pellicles were transferred to a Waring hiendo~ and ground in this for gIcE~au)  ~.  s~oP~  607 
3 to 4  minutes,  5  to 10 cc. of the culture fluid being added for each pellicle ground. The re- 
sulting gruel-like  suspension was  then  centrifuged  at  4-2000  R.p.~r.  for  20  minutes.  The 
supernatant, which was rich in antiviral activity, was decanted and saved for use in treat- 
ing infected mice. It was designated as the "supernatant of the pelllcle suspension" and will 
be referred to subsequently in this work as the "SPS." 
Experimental 
Tests  of  mold  preparations  for  therapeutic  activity  in  mice  infected  with 
Columbia SK encephalomyelitis virus were conducted in the following manner. 
White mice in groups of 6 animals per cage were infected by injection with the selected 
dilution of  SK  virus either intraperitoneally or  subcutaneously. The intraperitoneal route 
was used for only some of the early experiments. In most of those reported in the present 
paper the subcutaneous route has been employed as routine to avoid any possible in vitro 
effect of the antiviral substance administered intraperitoneally. Animals that were to serve 
as controls were either left untreated or received 0.5 cc. amounts of sterile fluid medium intra- 
peritoneally 3 and 24 hours after infection. Mice in which various mold preparations were 
to be tested for antiviral activity received these by the same routes and on the same injec- 
tion schedule as the controls received  the sterile medium. 
Mice dying during the first 48 hours after infection were not included in the experimental 
results but were classed toxic deaths. Mice dying from the 3rd day onward were considered 
to have succumbed to SK virus infections. 10 days was selected as the period of observation 
in these experiments since it has been our experience that mice which lived this long are likely 
to survive indefinitely. 
Since judgment of the therapeutic efficacy  of the various mold preparations tested was 
based on a comparison between the survival times of the control and of the treated mice, it 
was important that the time of death of individual mice be accurately recorded. Groups of 
infected mice were checked for dead  animals twice daily, and for statistical  purposes  the 
deaths were recorded in 24 hour periods, those of the afternoon reading with those  of the 
following morning. Mice that survived  10 days were  scored as having succumbed on the 
10th day. 
In selecting an appropriate method of evaluation it was found that the distribution of 
survivals in terms of log days more closely approached a  normal distribution than did the 
distribution of survivals in terms of days themselves (3). Accordingly, the number of deaths 
occurring in each group for each day was multiplied by the logarithm of the numerical day 
of the experiment and at the termination of the experiment the products were totalled for 
each treated or control group of mice to obtain the total log days survived. Division of the 
total log days by the number of mice in a particular group gave the mean log days of survival 
for the group, and the antilog of this value was the average survival time in days for the 
group.  A  comparison of the survival times in days of groups of treated animals, with the 
survival  time  of  untreated  control  animals,  was  achieved  by  dividing  the  values for 
the treated groups by the corresponding value for the control group.  The quotient of this 
division is a  value that enables one to judge the therapeutic efficacy of a  substance under 
test, and throughout the present paper this will be referred to as the survival index (SI). 
The minimum significant survival indexes have been calculated for us by Dr.  W.  I-I. Ott 
to be 1.31 when single groups of 6 mice were used in testing each substance. When more than 
single groups of 6  mice were employed,  the minimum significant values were  1.21 for two 
groups,  1.17 for three groups,  1.14 for four groups, and  1.13 for five groups.  We have not 
exceeded 30 mice (5 cages of 6 animals) per treated or control group in the present experi- 
ments and most of our work has been done using 6, 12, or 18 animals per group. 6O8  AN ANTIVIRAL SUBSTANCE FROM P.  FUN'ICULOSU~. I 
TABLE IV 
Comparative Antiviral Activity of the Fluid Portions of Stationary Cultures of Various Colony 
Isolates of P. funiculosum against Swine Influenza and Columbia SK 
Encephalomyditis Virus 
PreparationS: 
AH4 
AH 10 
AH 32 
AJ 21 
AJ 29 
AJ 61 
AJ 70 
AK 56 
AK 57 
AK 62 
AK 70 
AK 74 
AL3 
AL 10 
AL 22 
AL 26 
AL 39 
AL43 
AL 54 
AL 73 
AL 75 
AL 76 
AL77 
AL 78 
AL 85 
AL 98 
AM 24 
AM 33 
Survival index* 
Swine influenza  virus 
1.00 
1.27 
1.05 
1.25 
1.11 
0.76 
0.80 
1.09 
1.23 
1.13 
1.03 
1.02 
1.07 
1.04 
1.02 
1.07 
1.05 
1.33 
1.12 
0.94 
0.95 
1.04 
1.06 
1.37 
0.73 
1.13 
0.93 
1.19 
SK encephalomyelitis  virus 
1.11 
1.12 
1.32 
1.33 
1.24 
1.14 
1.33 
1.78 
1.87 
1.46 
1.57 
1.22 
1.29 
1.38 
1.19 
1.38 
1.29 
1.47 
1.39 
1.45 
1.37 
1.45 
1.28 
1.35 
1.42 
1.48 
1.20 
1.50 
* Tested in groups of 6 mice. 
These preparations were from cultures of the mold grown during the 4th year of our 
work. 
RESULTS 
In Table IV, results are recorded of a  group of experiments in which mice, 
infected with either  Columbia SK encephalomyelitis virus or  swine influenza 
virus,  were  treated  with  corresponding samples of  fluid from  stationary cul- 
tures of various colony isolates of  our strain of P. funiculosum. 
The  individual mold preparations included in Table IV were  administered 
intraperitoneally in 0.5  cc.  amounts to groups of 6  mice 3  and 24 hours  after 
either intranasal inoculation with  swine influenza virus or  intraperitoneal in- 
oculation with  SK  encephalomyelitis virus. Of  10  control groups of  mice for RICHA~  E. SHOPE  609 
each virus, all 60 of those infected with SK virus died within the 10 day period 
of observation,  while  58 of the 60 swine influenza controls also succumbed.  It 
is  evident  from  this  that  the  tests  for  therapeutic  efficacy  were  conducted 
against almost certainly fatal doses of virus.  Of the 28 treated groups of mice, 
11  of the  168  animals  infected  with  swine  influenza  virus  survived,  while  43 
of the  168  infected  with  SK  virus  lived.  From  consideration  of the  survival 
indexes recorded in the table,  it seems likely that,  with  the possible  exception 
of samples AL 43 and AL 78, the preparations exerted little if any therapeutic 
effect  against  swine  influenza  virus  infections.  Against  SK  encephalomyelitis 
virus  infections,  on the  other hand,  well  over half  of the  preparations  had  a 
significant  therapeutic  effect and a  few appeared  to be quite  highly active. 
These results strongly suggest that the substance from P. funiculosum  found 
earlier  to be  therapeutically  active  against  swine  influenza  virus  may not  be 
the same as that found active against SK virus. 
A  large amount of work has been conducted in an attempt  to obtain higher 
yields of the antiviral  substance from stationary broth cultures of P. funiculo- 
sum.  The  time  and  temperature  of incubation  have  been  varied,  attempted 
selection  of colonies for activity has been tried,  the constituents  of the media 
have been varied, and numerous other technical variations have been instituted, 
but  in no instance  have we come upon any procedure  that  appears  regularly 
and constantly to increase  the yield of antiviml  substance in the fluid portion 
of the  cultures.  In fact,  we were unsuccessful in outlining any procedure  that 
would even insure obtaining good activity from every harvest  of culture fluid. 
It was while attempting to increase our yields that we decided to explore the 
possibility  that  the  antiviral  activity  might  reside  in  the  solid  cellular  com- 
ponents of the pellicles. 
Antiviral Activity Extractable  from the Pdlicles 
The peUicles of P. funiculosum  grown in Blake bottles in stationary  culture 
are  thick,  fleshy,  spongy,  and  quite  saturated  with  fluid. 
In the experiments in which they were to be tested  for the presence of antiviral  sub- 
stance, they were sucked fairly free of adherent fluid on a gauze milk pad in a Buchner funnel 
and then homogenized in a Waring blendor with  approximately  equal  volumes of various 
solvents in the hope that one of the solvents would extract  the antiviral  substance from the 
bruised cellular components of the pellicles. Ethanol,  methanol, acetone, chloroform, physi- 
ologic saline buffered at pH 7.3, and culture broth itself were used as the extracting solvents. 
After  homogenizing, the pellicle-solvent mixture  was centrifuged  to separate  the solvent. 
This was collected by pipette.  The saline and culture broth extracfives were tested  for ac- 
tivity without  further treatment.  The other solvents used were evaporated  to dryness, and 
the residues taken up by triturafion  in a 2 per cent solution of methocel  1 in distilled water. 
They were made up in this  suspending medium to approximately  the same volume as the 
saline  and culture  broth preparations.  The various preparations  were administered  intra- 
peritoneally in 0.5 cc. amounts to groups of 6 mice 3 and 24 hours after intraperitoneai  inocu- 
lation with SK encephalomyelitis virus. The results obtained are given in Table V. 
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With two possible exceptions, none of the organic solvent extractives  of the 
pellicles exerted  a  favorable therapeutic  effect against  the  SK virus  infections 
TABLE V 
Comparalire Antiviral  Activity  of Variou~ Extracts of Pellicles of P. funioulosum  against SK 
Encepkalomyelitis Virus Infections of Mice 
PeUides  of  culture  No,  Extracted  with  Survival  index* 
8O 
82 
86 
88 
104 
I15 
116 
121 
119 
Ethanol 
Acetone 
Chloroform 
Ethanol 
Chloroform 
Ethanol 
Acetone 
Chloroform 
Buffered saline 
Methanol 
1.29 
0.94 
0.98 
0.94 
I. 14 
1.17 
1.14 
1.25 
1.48 
0.60 
Acetone 
Chloroform 
Buffered saline 
Acetone 
Chloroform 
Buffered saline 
Chloroform 
Culture broth (SPS)~ 
Chloroform 
Culture broth (SPS) 
Acetone 
Chloroform 
Culture broth (SPS) 
Chloroform 
Culture broth (SPS) 
0.80 
0.65 
1.20 
0.94 
0.77 
1.30 
1.18 
1.60 
0.96 
1.62 
1,16 
0.91 
1.41 
1.19 
1.30 
* Tested in groups of 6 mice. 
SPS, supernatant fluid of peUicles fragmented  in a Waring blendor  (see text). 
to  judge  by  the  low  survival  indexes  obtained.  The  two  exceptions,  ethanol 
extract of peUicles  of culture 80 and chloroform extract of culture  86,  gave sur- 
vival indexes that bordered on significance. The sahne and broth extracts of the 
various culture pellicles, on the other hand, all showed some evidence of thera- 
peutic activity and several were quite active to judge by the high survival in- ILICH.AI~D F..  SI-IOPE  611 
dexes  obtained.  There  appeared  to  be  some  advantage  in  the  use  of culture 
broth over buffered saline. 
It  seemed  apparent  from  this  experiment  that  considerable  antiviral  ac- 
tivity resided  in the cellular components of stationary cultures  of P. funiculo- 
sum and that this activity was extractable with aqueous solvents but not with 
the  organic  solvents  tried.  The  solubility  of the  antiviral  substance  in  water 
and  its  apparent  insolubility  in  acetone,  as evidenced by the  findings in  this 
experiment,  have been utilized as a  first step in the isolation of the active prin- 
ciple and will be discussed later. 
Comparison of the Anti~iral  Activity  of the Fluid Portions and  the Pellicles of 
Stationary Cultures of P. funiculosum 
With  the  finding,  outlined  in  Table  V,  that  extracts  possessing  antiviral 
activity could be obtained from the pellicles  of stationary cultures of P. funi- 
culosum by extraction  with either buffered saline or culture broth,  the sugges- 
tion  was  immediately  apparent  that  the  pellicles,  which  in  earlier  work had 
been discarded,  might be a  more potent and regular source of active material 
than the fluid portions of the cultures. To test this possibility, the fluid portions 
and  the  pellicle  extracts  of a  number  of groups  of cultures  (colony isolates) 
were tested in parallel for therapeutic activity. 
The pellicle extracts were prepared as outlined earlier by homogenizing the pellicles in a 
Waring blendor and adding 5 to  10 cc. of culture fluid for each pellicle during the blending 
process. The pellicle extracts (SPS) were thus in reality merely culture fluids containing anti- 
viral substance' liberated from the fragmented cellular constituents  of the pellicles. Pools of 
from 40 to 100 Blake bottle cultures were used in obtaining each sample of either pellicle ex- 
tract or culture  fluid tested.  Use of such large numbers of individual cultures in obtaining 
each sample served the double purpose of decreasing the likelihood of marked variation due 
to extremely active or inactive individual cultures and of furnishing larger amounts  of ma- 
terial for chemical work. 
The various culture  fluid and pellicle extract  preparations  were administered  intraperi- 
toneally in 0.5 cc. amounts to groups of 12 or more mice 3 and 24 hours after subcutaneous 
inoculation with  SK encephalomyelitis virus. The results obtained are recorded as survival 
indexes in Table VL 
As shown  in  Table  VI,  the  survival  indexes  given by 29  of the  30 pellicle 
extracts  were higher  than  the  indexes for the  corresponding culture  fluids.  In 
the  exceptional  case,  culture  BC  70,  the  fluid portion  of the  culture  for some 
reason  was  unusually  rich  in  antiviral  substance  and  gave  a  survival  index 
of 1.64 which equalled  that for the pellicle  extract.  22 of the 30 culture fluids 
exerted  a  significant  therapeutic  effect  against  the  SK virus  infections,  while 
all  the  pellicle  extracts  were  significantly  active.  The  average  survival  index 
for the 30 fluids was 1.27,  while for the 30 pellicle extracts it was 1.53.  Since at 
the  dosage of virus employed the  control animals  lived for an average of just 
under 5 days, these survival indexes meant a  prolongation of life of almost 1.5 612  AN ANTIVIRAL SUBSTANCE FROM P.  ]~UNICULOSL~. I 
days in the case of the fluids and of something over 2.5  days in the case of the 
pellicle extracts--an advantage of slightly over 1 day for the pellicle extracts. 
TABLE VI 
Comparative Antiviral  Activity  of Fluid Portions and the Pellicles of Stationary  Cultures of P. 
funiculosum  against SK Encephalomyditis  Virus Infections  in Mice 
P. /uniculosum 
culture No. 
BC 62 
BC 63 
BC 64 
BC 65 
BC 67 
BC 68 
BC 69 
BC 70 
BC 77 
BC 82 
BC 84 
BC 85 
BC 90 
BC 92 
BC 93 
BC 94 
BC 95 
BC 26 
BC 26A 
BC 26B 
BC 28 
BC 29 
BC 31 
BC 32 
BC 33 
BC 34 
BC 35 
BC 36 
BC 37 
BC 4O 
Fluid 
1.31 
1.21 
1.32 
1.21 
1.21 
1.28 
1.45 
1.64 
1.03 
1.08 
1.47 
1.22 
1.12 
1.45 
1.34 
1.34 
1.23 
1.37 
1.48 
1.26 
1.28 
1.14 
1.28 
1.18 
1.07 
1.18 
1.32 
1.50 
1.00 
1.26 
Survival index* 
Pelllcle (SPS) 
1.76 
1.65 
1.55 
1.48 
1.35 
1.52 
1.58 
1.64 
1.44 
1.62 
1.62 
1.76 
1.51 
1.58 
1.57 
1.44 
1.57 
1.56 
1.53 
1.54 
1.38 
1.52 
1.47 
1.40 
1.44 
1.57 
1.51 
1.56 
1.40 
1.45 
Average ........................  1.27  1.53 
* Tested in groups of 12 or more mice. 
It seemed clear from the experiments recorded in Table VI and from numerous 
others that have been conducted,  that much more antiviral activity resided in 
or remained in intimate association with the cellular constituents of stationary 
cultures  of  P. funiculosum  than  was  present  in  the  culture  fluid  itself.  As  a 
consequence of this observation we abandoned  our former practice of discard- ~E.  S~OPE  613 
ing the pellicles in favor of the broth portion of the cultures and began using the 
peUicles as our  source  of  antiviral  substance.  Because  of  the  usual  presence 
of a  certain amount of  antiviral activity in the fluid  portions of  the cultures, 
these fluids, instead of water or saline, were used as the solvent in extracting 
antiviral  substance  from  the fragmented  cellular constituents of  the  pellicles. 
Preference for culture fluid as extracting solvent was made purely on the basis 
of using  one  which  already contained  at least a  small amount  of the  desired 
antiviral substance. 
Precipitation of the Antiviral Substance with Acetone 
With the finding that fairly active amounts  of antiviral substance  could be 
regularly  extracted  from  the  fragmented  cellular components  of  the  pellicles 
of stationary cultures of P. funiculosum  by culture fluid or other aqueous sol- 
vents, it appeared that we were ready to attempt chemical isolation and puri- 
fication of the substance. The findings recorded in Table V, indicating that no 
active substance  could be  extracted from  the pellicles by treatment  with ace- 
tone,  suggested  the  use  of  this as a  first  step for precipitation of active ma- 
terial from the aqueous solvent. 
In a series of preliminary experiments it was found that the addition of 1 volume of chilled 
acetone to 1 volume  of the chilled pellicle extract (SPS) yielded a copious gummy,  sticky 
precipitate containing all or almost all of the antiviral activity. Trials of other proportions 
of acetone and SPS indicated that equal volumes represented the approximate optimum for 
precipitation of activity. Because of its sticky, gummy character and also because some of it 
remained in fine suspension which made filtration through paper difficult, the precipitate was 
collected  by centrifugation at about 2000 1LP.M. for 30 minutes.  The supernatant was de- 
canted and discarded and the brown, amorphous,  gummy precipitate was scraped from the 
bottom  and sides of the centrifuge  bottles with a spatula, using small amounts of distilled 
water. The material was readily though very slowly soluble in water and all of the precipitate 
could be finally gotten back into solution by triturating it thoroughly under small amounts 
of water with a spatula. In dissolving large amounts of the acetone precipitate, homogeniza- 
tion of it with water in a Waring blendor greatly hastened the process. It has been our prac- 
tice to take the precipitate up in a volume of water equal either to the initial volume of SPS 
or some fraction of that, usually one-half, for most of our tests. Because the resulting aqueous 
solution of the acetone precipitate is quite viscous, a concentration to less than one-fourth or 
one-fifth of the initial SPS volume is impractical owing to the extreme viscosity of the resulting 
more  concentrated  preparations. 
The  results  of  some  tests  comparing  the  therapeutic  activity of  the  redis- 
solved acetone precipitate with that of the original SPS are given in Table VII. 
It is evident, from the results presented in Table VII, that much or most of 
the  antiviral activity contained  in  the  crude  pellicle extracts  (SPS)  was  pre- 
cipitated by a  concentration of 50 per cent acetone. The method employed in 
assaying the therapeutic activity of the various preparations was too crude to 
permit the placing of much significance on small differences in the survival in- 
dexes shown by different preparations being tested. Also, as will be pointed out 
later when  the matter of dosage response comes up for consideration,  the ad- 614  AN  ANTIVIRAL  SUBSTANCE  ~'ROM  P.  FUNICULOSUM.  I 
ministration of  larger  amounts of  antiviral  substance above  a  certain  level 
fails to  improve the  therapeutic result achieved.  Many of  the  tests  recorded 
in Table VII were conducted at a  dosage level that lay within this "plateau" 
region of  diminishing response.  The gummy, amorphous precipitate obtained 
by the treatment of SPS with acetone is undoubtedly a  mixture whose exact 
TABLE VII 
Comparison of the Therapeutic Activity of Acetone Precipitates of SPS with the Original SPS 
against SK Encepkalomyelitis Virus 
Culture No. 
BC 90 
BC 91 
BC 64 
BC 64 
BC 63 
BC 63 
BC 62 
BC 55 
BC 55 
BC 54 
BC 54 
BC 48 
BC49 
BC 40A 
BC 40A 
BC 40B 
BC 40B 
BC 39 
BC 38 
BC 36 
BC 35 
SPS 
Survival index* 
1.51 
1.30 
1.55 
1.65 
1.70 
1.61 
1.34 
1.46 
1.48 
1.45 
1.60 
1.45 
1.47 
1.56 
1.51 
Acetone-precipitated  SPS 
Survival index  Concentratlon~ 
1.75 
1.47 
1.64 
1.44 
1.85 
1.33 
1.86 
1.60  2 
1.59  1 
1.57  2 
1.49  1 
1.38  1 
1.52  1 
1.51  1 
1.18  0.5 
1.55  1 
1.43  0.5 
1.40  1 
1.45  1 
1.43  1 
1.68  1 
2X 
2X 
2X 
lX 
4X 
lX 
2X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
* Tested in groups of 12 mice. 
On basis of volume d  original SPS (2 X means that the acetone precipitate was taken 
up in a volume of water equal to one-half that of the SPS from which the precipitate was de- 
rived). 
content of anfiviml substance is not known and may be quite small. The proc- 
ess,  however, provides a  crude means of  separating  the  active material  from 
some of  the  other constituents of  the  SPS  without appreciable loss of  its ac- 
tivity. In order  to  designate this active substance in terms  less  cumbersome 
and more specific than "antiviral substance or material," it will be referred to 
hereafter as helenine. This name is selected partly because it is non-descriptive 
and non-committal as to the nature of a  substance about whose mode of action 
and structure we are still ignorant, partly because it is, so far as I  am aware, 
not preempted, but largely out of recognition of the good taste shown by the RIC~E.  SHOPE  615 
mold producing the substance in locating on the picture of my wife, Helen, at 
the time of its isolation. 
Dosage Response to A cetone-Pr~ip4tate,  d Helenine 
As  indicated  in  the  preceding section,  the  therapeutic efficacy of helenine 
is  somewhat  peculiar in  that  a  dose  level exists above which  increasing  the 
amount administered does not improve the therapeutic result. Below this dose 
level there is a gradual falling off in therapeutic efficacy with diminishing doses 
of the material. This therapeutic plateau effect is illustrated by the composite 
experiment summarized in Table VIII. 
TABLE VIII 
Dosage Response to Acetone-Precipitaged  Hdenine of Mice Infected with SK Zneep~omyditis 
Virus 
Acetone precipitate of SPS culture No.  Total dose*  Survival index~ 
BC 56-59 
BC 63 
mg. 
11.0 
5.5 
2.75 
1.37 
0.55 
5.72 
1.43 
0.36 
0.09 
0.022 
1.87 
1.66 
1.74 
1.66 
1.33 
1.85 
1.33 
1.31 
1.06 
0.99 
* Administered intraperitoneally in 2 equal 
infection with SK encephalomyelitis  virus. 
Tested in groups of 12 or more mice. 
amounts 3 and 24 hours after subcutaneous 
In  this  experiment acetone precipitation  of the  SPS  of culture  BC  56-59 
yielded 5.5 mg. of precipitate per cc. while similar treatment of the SPS of cul- 
ture BC 63 yielded 1.43 mg. per cc. Administration of the precipitate BC 56-59 
in total dosages ranging from 1.37 to 11 mg. exerted a  good therapeutic effect 
in the treated mice, and the size of dose within this range seemed to make but 
little  difference in  the  eventual  outcome.  Decreasing  the  dose  from  1.37  to 
0.55  rag.  resulted in some slight falling off of the  therapeutic efficacy of the 
preparation. The acetone precipitate from culture BC 63 at a total dose of 5.72 
mg. gave a survival index that was roughly comparable with that achieved by 
the material from culture BC 56-59. However, progressive quartering of this 
dose resulted in a  falling off in therapeutic efficacy until at a  level of 0.09 rag. 
it was completely without therapeutic effect. No explanation is as yet evident 
for the plateau effect or why, beyond a  certain point, increasing the dose does 
not increase the therapeutic effect. 616  AN  ANTIVIRAL SUBSTANCE ~'RO~  P.  FUNICULOSUM. I 
The Influence  of Time of Administration  of Helenine on Its  Therapeutic Effect 
upon SK Encephalomyelitis Virus 
Preliminary experiments dealing with the comparative therapeutic effective- 
ness  of  1  treatment  dose  3  hours  after  infection,  as  compared  with  divided 
doses 3 and 24 hours after infection, indicated that, if the single dose was large 
enough  to  fall within  the  plateau  zone  of maximum  effect,  then  repeating  it 
24  hours  later  did  not  usually  increase  the  therapeutic  effect  materially.  If, 
however,  the initial dose at 3  hours yielded results below the plateau zone of 
maximum effect, then repeating it 24 hours later usually did improve the thera- 
peutic result as judged by the survival index. Since most of our work was with 
materials  whose  therapeutic  effectiveness  was  unknown,  we  treated  our  in- 
TABLE IX 
Influence of Time of Administration  of Hdenine on Its Therapeutic E~cacy  against SK En- 
cephalomyd#is Virus 
Treatment*  Survival  index  No. mice surviving 
of 24 
3 hrs. before infection 
3  "  after  " 
6  "  "  " 
12  "  "  " 
18  "  "  " 
24  "  "  " 
1.81 
1.70 
1.45 
1.45 
1.33 
1.18 
Controls, untreated ..............................  0 
* Single intraperitoneal injection of 3.5 mg.  dose of acetone precipitate of SPS culture 
BC 56-59 (Seitz-filtered). 
fected animals, as routine, 3 and 24 hours after infection to insure a  maximum 
effect, despite the fact that, with a  great many preparations, the 24 hour treat- 
ment dose was  found to be superfluous from the standpoint of improving the 
therapeutic end result. 
In experiments  set up to determine how long after infection helenine would still exert a 
therapeutic effect, only a  single treatment dose was  administered at various set intervals 
before or after infection. The experiment recorded in Table IX is typical of several that have 
been conducted and in it the mice were given a single treatment with a known active acetone- 
precipitated SPS  (a preparation from culture BC  56-59 whose titration is shojvn in Table 
VIII). 24 mice were treated intraperitoneally in each group  at various intervals before or 
after injection subcutaneously  with a dose of SK encephalomyelitis virus adequate to kill all 
24 untreated control mice. The results are shown in Table IX. 
As shown by the experiment outlined in Table IX, a  single dose of helenine 
given either 3 hours before or 3 hours after infection exerted a  good therapeutic 
effect against an SK virus infection and there was only slight falling off in thera- 
peutic effect when treatment was delayed 6 to 12 hours after infection. In other XUC~Am~ E.  s~oPE  617 
experiments  in  which  groups  of  mice  have  received  treatment,  beginning  at 
hourly  intervals  after  infection,  there  has  appeared  to  be  little  variation  in 
therapeutic  effectiveness for  at  least  10  hours.  In  the present experiment,  as 
well as in others that have been  carried out,  delay of treatment for  18  hours 
results in a  definite lessening of therapeutic effectiveness of helenine, and when 
given after 24 hours the survival index that can be achieved is still lower. Treat- 
ment delayed until the onset of definite signs of illness in the infected mice is 
completely without favorable effect. 
TABLE X 
Role of Size of Infecting Dose of Virus on Therapeutic,  Effect A thieved by Treatment with  Helenine 
Dilution of infected  brain  s 
1 X  10-~ 
2.5 X  10  -a 
1.25 X  10  -t 
8.3 X  10  -a 
6.25 X  10  -~ 
Average time  survived 
Controls  Treated~ 
days 
7.06 
8.20 
8.60 
8.78 
8.14 
days 
4.8 
4.6 
5.3 
5.7 
5.3 
Survival  index 
1.47 
1.78 
1.62 
1.54 
1.53 
* 30 mice infected subcutaneously in each treated and untreated group  at  each virus 
dilution; 0.5 cc. was volume of inoculum. 
Treated intraperitoneally with acetone precipitate of SPSBC  194 3 and 24 hours after 
infection. 
Role  of Size  of Infecting  Dose  of  Virus  on  the  Therapeutic  Effect  Achieved  by 
Treatment  with Helenine 
In  the  experiments described in  the  present paper we  have  endeavored  to 
use an infecting dose of SK virus that is between 10 and 1000 times that which 
will kill all or almost all the untreated control mice. Ordinarily, with this dose 
of virus  the  control groups  will succumb  in between  4.5  and  5.5  days, while 
animals treated with good preparations of helenine will survive long enough to 
give averages of from 7.5  to 8.5  days for the treated groups. In order to learn 
whether the apparent therapeutic effectiveness of a  preparation might be modi- 
fied by variation in the initial infecting dose of virus, several experiments have 
been carried out, and one is recorded in Table X. 
In the experiment shown in Table X, 5 groups of 60 mice each were infected subcutaneously 
with 0.5 co. doses of SK virus, diminishing by progressive increments.  One-half of the mice 
in each group were injected intraperitoneally with sterile broth 3 and 24 hours after infection 
and were designated as controls. The other half were treated intraperitoneally  with an acetone 
precipitate of SPSBC  194 3 and 24 hours after infection receiving a total of 24.4 rag. of the 
acetone precipitate. 
As can be seen from the results presented, helenine exerted a  favorable thera- 
peutic effect in all 5  groups of mice infected with various doses of SK virus. 618  AN" ANTIVIRAL  SUBSTANCE FROM  P.  FUNICULOSU~. I 
Delaying Effect of ttelenine on Invasion of the Brains of Infected Mice by SK Virus 
Although  in  a  number  of  trials  we  have  obtained  no  clear  cut  evidence  to 
indicate  a  direct in vitro action of helenine on  SK virus,  some of our evidence 
TABLE XI 
Titre of SK Virus in Brains of Treated and Control Mice SacriJ~ed at Various Intervals after 
Infection* 
Control mouse  Time after infection  Greatest dilution of infected brain killing 
No.  all mice on. titrationt 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Treated mouse~ 
No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
days 
2 
2 
2 
3 
3 
3 
3 
3 
3 
4 
4 
4 
<1 X  10  II 
1  X  10  -1 
1  X  10  -2 
1X  10-* 
<1  X  10-1 
1  X  10-  6 
1X  10-* 
1  X  10-  5 
1  X  10  -b 
1  X  10  -~ 
1  X  10-  4 
1  X  10  -5 
<1  X  10  -1 
<1  X  10-1 
<1  X  10-1 
<i  X  10  "z 
<1  X  10-' 
<1  X  10-1 
1 X  10-~ 
1 X  10-* 
1 X  I0  -s 
1X  10-~ 
1 X  10-  s 
<1  X  10  -1 
* Mice infected subcutaneously. 
Mice in  fitrations were inoculated intraperitoneally in groups  of 4  or 6  with 0.5  cc. 
mounts of the dilutions of infected brain recorded. 
§ Treated intraperitoneally with helenine 3 and 24 hours after infection. 
indicates  that  it has  an in vivo activity either  on  the  rate  of multiplication  of 
the virus or on  its rate  of invasion of the  central  nervous system.  When  indi- 
vidual  mice  were  sacrificed  at  varying  intervals  after  subcutaneous  infection, 
it was  found  that  the brains  of untreated  control animals  contained  easily de- 
tectable amounts of virus on the 2nd day  after infection and larger amounts on RICIKARD E. SHOPE  619 
the 3rd and 4th days after infection. The brains of  mice that had been treated 
with helenine, on the other hand, did not contain detectable virus on the 2nd 
day and were sometimes even free from it on the 3rd day. By the 4th day after 
infection virus was ordinarily present in their brains though in unusually low 
titre.  The findings of a  typical experiment are recorded in Table XI. 
In this experiment 12 infected untreated control mice and a similar number of animals 
treated in the usual manner with helenine were sacrificed at intervals of 2, 3, or 4 days after 
subcutaneous infection. Their brains were removed aseptically, ground in a mortar, and sus- 
pended in buffered saline to make a 10 per cent suspension by wet brain weight. This initial 
suspension was further diluted by progressive steps of 10 in buffered saline and the series of 
dilutions were administered intraperitoneally  to 4 or 6 mice in 0.5 cc. dosage. The titration 
end-point of infectivity for each brain was selected as the greatest dilution of infected brain 
which killed, with typical  manifestations,  all the mice in its group. While this end-point 
possibly represents a less accurate method of titration than one utilizing the so called 50 per 
cent end-point, it is believed to be adequate for the present purpose of determining a differ- 
ence in the virus content of the brains of treated  and untreated mice. 
Of the brain samples in which 0.5 cc. of a 10 per cent suspension intraperitoneally failed 
to kill the test mice  in the titration (<1 X 10-1), the samples from control mouse 5 and from 
treated mice 1, 2, 3, 4, 5, 6, and 12 are believed to have been completely free of virus because 
none of the test mice died and all appeared normal at the end of the  10 day period of ob- 
servation. On the other hand, the brain of control mouse 1 also recorded as fiterlng <1 X 10  -1 
probably contained a small amount of virus since i  of the 4 animals injected with that dilu- 
tion died showing typical signs of SK virus infection. 
The brains of the control mice killed on the 3rd or 4th day after infection contained an 
amount of virus such that 0.5 cc. of a 1 X  10  -4 or b dilution represented the regularly fatal 
titration end-point. The brains of the treated  mice, on the other hand, that contained any 
detectable virus on the 3rd or 4th day after infection had titres such that 0.5 ec. of a 1 X 
10-~ or ~ dilution  was  required  regularly  to  kill  the  test  mice. 
The evidence presented in Table XI indicates that helenine had a  delaying 
action on the neuroinvasiveness  of SK virus and may sometimes also have ma- 
terially slowed its rate  of multiplication in the  central nervous system. From 
the  findings presented  it  would appear  that  treatment had  delayed  invasion 
of the brain for from 24 to 48 hours and that, on the 3rd or 4th day after in- 
fection, the fitre of virus in the brains of those treated animals that were by 
now infected was in the neighborhood of about 1 per cent of that in the brains 
of corresponding untreated control animals. 
That the virustatic effect of helenine is not one that prevails right up to the 
fatal termination of an SK virus infection of mice is indicated by the findings 
in the experiment recorded in Table XII. 
In this experiment the brains of 4  untreated control mice dying on the 4th, 
5th, or 6th day, and of 9  treated mice dying on from the 5th to the 8th days 
after  infection were  harvested soon after  death.  They were  titrated for  their 
virus content in the  manner already outlined for  the  experiment recorded in 
Table XI. The findings indicated that the amount of SK virus in the brains of 
mice  at  the  time  of  death  was  approximately the  same  whether  or  not  the 
animals had been treated with helenine. The effect of helenine would therefore 620  AN  ANTIVIRAL  SUBSTANCE  ~"ROM P.  ~'UNICULOSUM. I 
appear  to be merely one of delaying or postponing  the build-up  in virus  to its 
lethal level in the central nervous system. 
TABLE XII 
Titre of SK Virus in Brains of Treated and Control Mice at Time of Death* 
Control mouse  Day of death  Greatest dilution of infected brain killing 
No.  all of mice on titrationt 
1  4  >i  X  10  -7 
2  5  1 X  10  -6 
3  5  1 X  10  -4 
4  6  1 X  10  -s 
Treated mouse~ 
No. 
1 X  10  -6 
1 X  10  -6 
> I  X  I0-~ 
1 X  I0  -e 
1 X  I0  ~ 
1 X  I0  -e 
1 X  I0  -6 
1 X  I0  -7 
>1  X  10  -7 
* Mice infected subcutaneously. 
Mice in titrations were inoculated intraperitoneally in groups of 4 with 0.5 cc. amounts 
of the dilutions of infected brain recorded. 
§ Treated intraperitoneally with helenine 3 and 24 hours after infection. 
TABLE XIII 
Additive Therapeutic Effect of Hdenine and Specific Antiviral Serum 
Treated with 
Activity a(gainst SK virus 
infection 
Survival index [  Survivors 
J 
Helenine 3 and 24 hrs. after infection  1.38  I  1/12" 
Anti-SK serum 48 hrs. after infection  0.96  0/12 
Helenine 3 and 24 hrs. and anti-SK serum 48 hrs. after infection  1.66  6/12 
Controls, average days survived =  4.6  1/18 
Surviving mice. 
No. of mice in group" 
Additive Therapeutic Effect of Helenine and Specific Antiviral Serum 
Further  in support  of  the  above view are  experiments  in which  an  additive 
therapeutic  effect  of  helenine  and  specific  virus-neutralizing  serum  was  ob- 
served.  The virus-neutralizing  serum  was  obtained  from swine  recovered from RICHARD  E.  SHOPE  621 
intracerebral  infection  with  SK  virus.  One  such  experiment  is  presented  in 
Table XIII. 
In this experiment 4 groups of mice were infected subcutaneously in the usual manner 
with SK virus. 1 group was then injected intraperitoneally 3 and 24 hours later with helenine, 
another group was given a single intraperitoneal injection of swine anti-SK virus serum 48 
hours after infection, a 3rd group was given the combined treatment  of the first 2 groups 
(helenine 3 and 24 hours and anti-SK virus serum 48 hours after infection), while the 4th 
group served as controls and were injected intraperitoneally with sterile broth 3 and 24 hours 
after infection. 
It was found that anti-SK virus serum given 48 hours after infection exerted 
no sparing effect despite the fact that,  from other experiments,  it was known 
that such serum, given 3  or 6 hours after infection, was completely protective 
against  the lethal effects of SK virus.  Helenine,  on the other hand,  exerted a 
moderate therapeutic effect on the group of infected mice to which it was ad- 
ministered, as evidenced by a  survival index of 1.38 for the group. However, a 
still better therapeutic result was achieved in the group of mice treated with 
both helenine and anti-SK virus serum. Here the survival index was 1.66  and 
half of the mice were actually saved. It is believed that results such as these fall 
in line with  the findings outlined  in Table VIII and can best be explained on 
the  basis  of  an  inhibition  of virus  multiplication  or  invasion  of  the  central 
nervous system for 48 to 72 hours by helenine, with a  consequent favorable re- 
sult from virus-neutralizing serum given  late during  this period of virustasis. 
The action of the helenine in this experiment is visualized as that of a virustatic 
agent which prolongs the period during which specific virus-neutralizing serum 
can exert its virucidal activity. 
RECAPITULATION  AND  DISCUSSION 
The  evidence  obtained  in  this  study  indicates  that  a  substance,  which  we 
have  chosen  to  call  helenine,  produced  by  _P. funiculosum, and  particularly 
plentiful in the cellular elements of stationary cultures of this mold, is capable 
of exerting a marked modifying effect upon the course of infection with Columbia 
SK encephalomyelitis virus in mice. A  substance produced by this same mold 
culture  during  the first 2 years after its original isolation and  therapeutically 
active against infection with swine influenza virus in mice is believed to differ 
from  helenine.  The  original  antiviral  substance  was  present  in  the  fluid 
portions of stationary cultures of P. funiculosum and was highly active against 
the  swine  influenza  virus.  Unfortunately during  the  time  that  this  substance 
was available for work we did not conduct studies designed to characterize it 
for later comparison with other antiviral] substances  that  the mold might pro- 
duce.  As has been pointed out,  our mold culture,  as work with it progressed, 
gradually became more irregular  in  its production  of the  anti-influenza  virus 
substance until  finally  it  lost almost completely its capacity to produce  it. 
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of mice, was not looked for or observed until the 4th year of our work, after the 
culture had apparently largely lost its capacity to produce the anti-influenza 
virus  substance.  Hence  there  has been  no  opportunity to  compare  helenine 
with the antiviml substance  that  first attracted  our attention. That helenine 
and  the initial antiviml substance are qualitatively quite different is indicated 
by the results with culture fluids, shown in Table IV of the present paper. Many 
of the preparations presented in this table were quite high in helenine activity 
when tested against SK virus, but completely devoid of therapeutic effect on 
swine influenza virus infections. In other experiments, SPS or acetone precipi- 
tates of SPS that were highly effective in treating SK virus infections, were com- 
pletely without effect when used  against swine  influenza virus  infections. A 
conclusion that seems warranted  from the results of  numerous tests  in which 
preparations were therapeutically active against SK virus but devoid of effect 
on swine influenza virus infection is that, whatever the substance initially pro- 
duced by P. funiculosum,  it was not the one to which we refer in this and sub- 
sequent papers as helenine. On the other hand, the production of helenine by 
the mold has not diminished as time has elapsed and, so far as can be told, our 
culture is as active today in producing the substance as it was when the ac- 
tivity was first observed. 
The finding of greater helenine activity in association with the cellular ele- 
ments of the pellicles  than in the culture fluids themselves probably indicates 
that helenine is largely an intracellular material diffusing into the surrounding 
medium only irregularly and usually in small amount. It appears to be liber- 
ated in quantity only when the cellular components of the pellicles are bruised, 
fractured,  and  fragmented  by  mechanical  means.  Once  liberated  from  the 
broken cells  it  is soluble in water or the  surrounding  aqueous  medium. As 
shown in this study, it can be precipitated, probably completely, from aqueous 
solution by organic solvents that are  freely soluble  in water.  We have used 
acetone largely as the precipitant although either methyl or ethyl alcohol are 
satisfactory. Unfortunately, from the standpoint of purification or isolation of 
helenine,  precipitation  with  acetone  is  not  discriminatively selective  for  it, 
and other substances come down in the precipitate. There is no way of knowing, 
from the work carried out thus far, just what proportion of a  given acetone 
precipitate is compr/sed of helenine but it may be quite small. Certainly there 
is frequently no direct correlation between the amount of acetone-precipitable 
material present in a  crude SPS and its helenine content as judged by thera- 
peutic activity against SK virus. 
The quantitative determination of the helenine content of various prepara- 
tions is handicapped by the plateau effect regularly observed in titrations of 
helenine activity. Furthermore, the failure of infected animals to respond more 
favorably to multiple injections of helenine than to single doses when the dose 
falls within the plateau zone of maximum effect is not adapted to work of a 
quantitative  character.  That  a  dosage  response  to  helenine  can  be  demon- raCmtRDE.  SgOPE  623 
strated is dearly shown in the experiment outlined in Table VIII, and many 
others like it that have been conducted, but the range in which difference~ can 
be observed is at the very low dosage levels. The disappointing state of affairs 
is that, while a helenine dosage effect or response can be shown by decreasing 
the amount administered below what appears  to  be  a  certain optimal level, 
a  material improvement in therapeutic response cannot be elicited by increas- 
ing the dose above this level or by increasing the number of times the substance 
is administered. The case of helenine constitutes a  refutation of a  rather fixed 
therapeutic belief that if a little treatment is good a lot of treatment should be 
better, and the limiting factor with helenine in this instance is not toxicity re- 
sulting from the large dose. Rather the limiting factor of helenine therapeutic 
effect on SK virus infections in mice would seem in some way to be associated 
with the mechanism by which helenine exercises its antiviral action,  a  factor 
which will be more completely discussed in a  later paragraph. 
The time at which treatment with helenine is begun is an important factor in 
achieving a  favorable therapeutic result in infected mice. There is little if any 
advantage  to  beginning  treatment  before  infection.  However,  delay  in  be- 
ginning treatment beyond 6  to  10 hours after infection results in progressive 
diminution in the  effectiveness of treatment judged on the basis  of survival 
indexes.  Delay of treatment for 18 hours results in a definite lowering of thera- 
peutic effectiveness and at 24 hours the survival index that can be achieved is 
even lower though still statistically significant. Helenine exerts  no favorable 
therapeutic effect if its administration is delayed until the infected mice show 
actual signs of illness. 
If the dose of SK virus used to infect mice is massive, helenine is without 
effect in modifying the course or outcome of the infection. The most clear cut 
therapeutic results are obtained against from 10 to  1000 surely fatal doses of 
virus and the maximum therapeutic effect is achieved at a  level of infection 
that kills untreated mice in an average of about 5  days. 
From the facts discussed thus far it is quite apparent  that helenine would 
have  no  practical  value  in  treating  naturally  occurring  outbreaks  of  virus 
diseases  resembling the experimental SK virus infections in mice. In order to 
achieve a  favorable therapeutic result, considerable jockeying of experimental 
conditions is required, and it seems  doubtful that these specialized  conditions 
would be  met under any conceivable set of natural  circumstances. The fact 
should however be borne in mind that the  SK virus, once it has elicited signs 
in mice, regularly proceeds to a  fatal termination and it is conceivable that 
the experimental test of therapeutic efficacy is more severe than would have 
to  be  met under natural  conditions of disease and  with viral  infections less 
regularly fatal in their outcome. This possibility would have to be taken into 
consideration before  categorically deciding,  on  the  basis  of results  with  SK 
virus alone, that helenine has no practical application in virus therapensis. 
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therapeutic effect on SK virus infections in mice appears in some way to be 
associated with the mechanism by which it exercises its antiviral action. While 
the exact mechanism is not known, some of the experimental work here pre- 
sented,  especially that  outlined in Tables XI,  XII,  and XIII,  suggests what 
it  may be.  The experiments represented in  the  first of these  tables  indicate 
quite clearly that treatment of infected mice with helenine delays the entrance 
of virus into the brain for from 24 to 48 hours. They further indicate that on 
the 3rd or 4th day after infection the titre of virus in the brains of those treated 
mice that were by then infected was only about 1 per cent of that in the brains 
of corresponding untreated animals.  Two possible explanations of these  find- 
ings are apparent. One of these is that helenine causes an inhibition, or interrup- 
tion,  of multiplication of the  virus,  with  a  consequent slowing  down  of the 
whole process of infection and spread to the central nervous system. The other 
is that helenine in some way interferes temporarily with the neuroinvasiveness 
of the virus. That the effect of helenine on the virus, whatever it may be, is not 
one that prevails right up  to the fatal termination of the  SK virus infection 
is indicated by the findings in the experiment presented in Table XII. In this 
experiment, the findings indicate that at the time of death there is no essential 
difference in the amount of SK virus in the brains of mice, whether or not they 
had been treated with helenine. The effect of helenine would, therefore, appear 
to be one to delay the build-up in virus to its lethal level in the central nervous 
system. Further  in support of this view is  the experiment outlined in Table 
XIII,  in which  an  additive  therapeutic effect of helenine and  specific virus- 
neutralizing serum was  observed. In this  experiment specific antiviral  serum 
given 48 hours after infection exerted a life-saving effect on mice that had been 
treated with helenine but was  completely without effect on untreated  mice. 
The action of the helenine under such circumstances is visualized as that of 
a  virustatic substance prolonging the period during which  specific virus-neu- 
tralizing serum could exert its virucidal activity. All of the information brought 
to light in this study of the effect of helenine on SK virus infections indicates 
its action to be that of a substance acting either by inhibition of multiplication 
of the virus or by interference temporarily with its neuroinvasiveness. 
Similar experiments with Semliki Forest virus to be reported in an accompany- 
ing paper (4) have yielded findings which make possible further elucidation of 
the possible mechanism of the action of helenine in favorably influencing viral 
infections.  These findings  will  be  discussed  in  connection with  the  study  of 
Semliki Forest virus. 
SUMMARy 
A culture of P. funiculosum isolated on Guam proved capable of elaborating 
a  substance  which  exerted  a  favorable  therapeutic  effect against  swine  in- 
fluenza virus infections in white mice. The culture was extremely variable and RICHARD E.  SHOPE  625 
irregular in its production of the antiviral substance, and during maintenance 
in the laboratory for several years gradually lost this property. Efforts to re- 
store it were unsuccessful. 
Subsequently it was found that the mold elaborated a substance, now desig- 
nated  helenine,  which  is  therapeutically effective against  Columbia  SK  en- 
cephalomyelitis virus infections in mice. Helenine appears  to  differ from the 
substance earlier procured from the mold, which was active against swine  in- 
fluenza virus  infections in mice.  It is frequently present in greater or lesser 
amount in the fluid portions of stationary cultures of P. funiculosum but is more 
regularly obtained and in larger amount, from the cellular components of the 
peUicles. When liberated from these latter by mechanical bruising and fractur- 
ing, it goes into solution in the culture fluids. It is precipitable from aqueous 
solution by 50 per cent acetone. 
Infected mice injected with helenine in amounts less than the amount which 
produces a  maximal therapeutic effect exhibit a  dosage response.  Increasing 
the dose above the optimum fails to increase the therapeutic effect. 
Helenine exerts  its maximum effect when given within  the first  10  hours 
after viral infection but its influence is apparent even when treatment is de- 
layed for up to 24 hours. It is not effective against massive amounts of virus 
and gives the best therapeutic results when used in the treatment of animals 
infected with from 10 to 1000 fatal doses of virus. Treatment of infected mice 
with helenine delays the entrance of virus into their brains for from 24 to 48 
hours. 
The mechanism by which helenine exerts its therapeutic effect against SK 
virus is not known but the findings presented suggest either that it muses an 
inhibition  or  interruption  of  multiplication  of  the  virus,  slowing  down  the 
whole process of infection and spread to the central nervous system, or that in 
some way it interferes temporarily with the neuroinvasiveness of the virus. 
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